Hipradog DP lyofilizát a tekutá zložka na injekčnú suspenziu
Hipradog DP lyofilizát a tekutá zložka na injekčnú suspenziu
Authorised
- Canine parvovirus, strain Cornell 780916, Live
- Canine distemper virus, strain Lederle, Live
Product identification
Medicine name:
Hipradog DP lyofilizát a tekutá zložka na injekčnú suspenziu
Active substance:
- Canine parvovirus, strain Cornell 780916, Live
- Canine distemper virus, strain Lederle, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain Cornell 780916, Live7.00/log10 tissue culture infective dose 501.00millilitre(s)
-
Canine distemper virus, strain Lederle, Live5.00/log10 tissue culture infective dose 501.00millilitre(s)
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
-
All relevant tissuesno withdrawal periodnot applicable
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/066/04-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 13/12/2021
How useful was this page?:
